Diagnosis and Management of Diabetes Mellitus
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 38
Special Issue Editors
Interests: proteomics; metabolomics; coagulopathy; diabetes; natural products; public health; molecular biology; bioinformatics
Interests: endocrine biomarkers (thyroid disease, diabetes); cardiac biomarkers (troponin, BNP, Galactin3, Lipids); COVID-19 biomarkers (antibodies, antigen); cancer biomarkers (HE4, circulating tumor cells); lab management (POCT, accreditation, LEAN)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will focus on highlighting advanced diagnostic approaches, molecular biomarkers, integrative technologies, and improved therapeutic strategies for better control of diabetes mellitus and its complications. The integration of diagnostic precision into therapeutic decision-making is critical in addressing the complex nature of diabetes and preventing its progression to complications such as nephropathy, retinopathy, and cardiovascular disease. Submissions that explore innovative diagnostic techniques, population-specific interventions, and novel management approaches, including, but not limited to, personalized medicine, lifestyle interventions, and phytotherapeutics, are welcome. We invite all researchers in this field to submit contributions to this Special Issue in the form of systematic reviews, original research articles, or communications.
Dr. Franklyn Iheagwam
Prof. Dr. Aw Tar-Choon
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes diagnosis
- glycemic monitoring
- personalized treatment
- chronic complications
- point-of-care testing
- insulin resistance
- diagnostic biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
